(HNGN) – Promising new research suggests patients with low testosterone levels who have gone one testosterone replacement therapy (TRT) could have a lower risk of cardiovascular events including heart attack and stroke.

A team of researchers looked at incidents of “heart attack, stroke, and all-cause mortality” in both treated and untreated patients, Oxford University Press reported. The major study is the largest cohort of patients and the longest follow-up for testosterone replacement therapy ever conducted.

The study included 83,010 male veterans who did not have a history of myocardial infarction (MI) or stroke and were given TRT between December 1999 and May 2014. The researchers found only 63 percent of the patients achieved normal testosterone levels following the treatment, and those who did reach normal levels were less likely to suffer serious cardiovascular events.


Leave a comment

Your email address will not be published.